
INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC
The FDA granted an orphan drug designation (ODD) and a rare pediatric disease designation (RPDD) for INF108 (Infinant Health) for the prevention of necrotizing enterocolitis (NEC) in preterm infants. The manufacturer is planning to initiate a human …